Professor Robin Feldman is quoted in a Wired article entitled “Crispr Gene-Editing Upstart Editas Goes Public as Patent Battle Rages.”

Tweet about this on TwitterShare on LinkedInShare on FacebookShare on Google+Email this to someone

“’The patent system lumbers on. But innovation is on its own timeline,’ says Robin Feldman, a professor at the UC Hastings Law School. ‘It’s not going to wait, certainly not going to wait years, for an invention that could be so revolutionary. Everyone is afraid of missing out on something with so much potential.’”

The full article can be found here.

Tweet about this on TwitterShare on LinkedInShare on FacebookShare on Google+Email this to someone

Comments are closed.